
Regeneron Pharmaceuticals, Inc.
NASDAQ:REGN
Overview | Financials
Company Name | Regeneron Pharmaceuticals, Inc. |
Symbol | REGN |
Currency | USD |
Price | 678.42 |
Market Cap | 72,935,577,360 |
Dividend Yield | 0% |
52-week-range | 642 - 1,211.2 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Leonard S. Schleifer M.D., Ph.D. |
Website | https://www.regeneron.com |
About Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD
